Improving cell-based bioassay efficiencies for cell & gene therapies webinar

In "Improving cell-based bioassay efficiencies for cell & gene therapies," Amruta Kale, senior method development scientist of immunochemistry, discussed key challenges faced with cell-based bioanalytical assays to support cell and gene therapies, a forward-thinking approach to drive client efficiencies for these newer modalities, and key learnings surrounding our efforts utilizing SVAR iLite® technology for AAV gene therapies.